Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

Clinical trial NCT06987916 · RECRUITING

Trial details

NCT number: NCT06987916
Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B Cell Lymphoma

Start date: 2025-04-22
Primary completion: 2028-04-22
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.